Literature DB >> 2375911

Increased red blood cell aggregation in retinal vein occlusion.

A Chabanel1, A Glacet-Bernard, F Lelong, A Taccoen, G Coscas, M M Samama.   

Abstract

Reversible aggregation of red blood cells (RBC) plays an important role in determining the flow properties of blood, and is the cause of the increase in blood viscosity at low shear rates. Retinal venous circulation is characterized by the combination of a low flow state and a high vascular resistance which might severely limit its capacity to adjust to high blood viscosity. These characteristics make the venous circulation in the retina particularly dependent on haemorheological factors. To test the possibility that high RBC aggregation could predispose to the onset and development of retinal vein occlusion (RVO), RBC aggregation and disaggregation (SEFAM erythroaggregameter, France) were measured in 64 patients with RVO. Results were compared to those of a group of 64 controls, similar in age, sex, smoking habit and associated pathologies. Increased RBC aggregation was observed in 52% of the patients, and the mean values showed a highly significant elevation of RBC aggregation parameters in RVO patients (+14%) when compared with controls (P less than 0.001). Subgroups were compared to study the influence of site (central versus branch), form (ischaemic versus non-ischaemic), duration and severity of the occlusion on the aggregation parameters. No significant differences were found between these various subgroups. An increase in RBC aggregability and in the shear resistance of RBC aggregates, by predisposing to circulatory stasis, is likely to contribute to the onset of RVO.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375911     DOI: 10.1111/j.1365-2141.1990.tb02628.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Haemorheology in patients with branch retinal vein occlusion with and without risk factors.

Authors:  A Remky; O Arend; F Jung; H Kiesewetter; M Reim; S Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year.

Authors:  S Arséne; B Giraudeau; M-L Le Lez; P J Pisella; L Pourcelot; F Tranquart
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

4.  Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.

Authors:  T H Williamson; A Rumley; G D Lowe
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

5.  Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study.

Authors:  Agnès Glacet-Bernard; Marielle Atassi; Christine Fardeau; Jean-Paul Romanet; Matthieu Tonini; John Conrath; Philippe Denis; Martine Mauget-Faÿsse; Gabriel Coscas; Gisèle Soubrane; Eric Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-17       Impact factor: 3.117

6.  Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion.

Authors:  H C Chen; J Wiek; A Gupta; A Luckie; E M Kohner
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

Review 7.  New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion.

Authors:  Jia Li; Yannis M Paulus; Yuanlu Shuai; Wangyi Fang; Qinghuai Liu; Songtao Yuan
Journal:  J Ophthalmol       Date:  2017-03-12       Impact factor: 1.909

8.  Effect of a Dexamethasone Implant on Rheological Blood Parameters in Patients Treated for Retinal Vein Thrombosis.

Authors:  Dorota Śpiewak; Anna Heinke; Katarzyna Michalska-Małecka
Journal:  Int J Gen Med       Date:  2022-08-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.